Diffusible suppressor factor from splenic macrophages in murine plasmacytoma

Insights

Splenic macrophages produce a diffusible suppressor factor (DSF) that inhibits immune responses in mice with plasmacytoma. This non-immunoglobulin protein is crucial for tumor progression and requires continuous synthesis.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Splenic macrophages (M phi) in tumor-bearing mice exhibit immunosuppressive properties.
  • This immunosuppression is mediated by a diffusible factor (DSF).

Purpose of the Study:

  • To characterize the nature and production of the diffusible suppressor factor (DSF).
  • To elucidate the molecular properties and synthesis requirements of DSF.

Main Methods:

  • Biochemical analysis of DSF (non-dialyzable, heat-sensitive, trypsin-sensitive).
  • Ligand binding assays using myeloma proteins and specific ligands (dinitrophenyl L-lysine, dextran S).
  • Immunological assays with anti-idiotypic and anti-isotypic antibodies.
  • Inhibition studies using metabolic inhibitors of RNA, protein, and DNA synthesis.

Main Results:

  • DSF binds to ligands specific for corresponding myeloma proteins.
  • DSF cross-reacts with anti-idiotypic antibodies but not anti-isotypic antibodies to mouse immunoglobulins (Ig).
  • DSF production is blocked by inhibitors of RNA and protein synthesis, but not DNA synthesis, indicating it is a non-Ig protein.

Conclusions:

  • DSF is a novel non-Ig protein produced by splenic suppressor M phi.
  • DSF possesses structural similarities to myeloma idiotype.
  • Continuous RNA and protein synthesis are essential for DSF elaboration by M phi.